What Happened

Two nurses at UT Southwestern Medical Center's Clements University Hospital were found dead in hospital bathrooms after overdosing on diverted fentanyl — one on December 15, 2016, and another on April 16, 2018.

Federal investigators concluded that the deaths were the visible consequence of a broader institutional failure: UT Southwestern failed to maintain effective controls and records for controlled substances and failed to report theft to the DEA in a timely manner. Those gaps enabled nurses to divert fentanyl and other controlled substances from automated dispensing cabinets and medication areas across Clements University Hospital and the Zale Lipshy Pavilion.

On November 30, 2021, UT Southwestern agreed to pay a $4.5 million civil penalty and implement a corrective action plan to resolve alleged Controlled Substances Act violations. The settlement was the largest hospital drug-diversion settlement in Texas and the second largest nationally.

What Went Wrong

This case illustrates how weak institutional controls — not just a single bad actor — allow diversion to persist until it becomes lethal. The two deaths came roughly sixteen months apart, which suggests the underlying control failures were systemic and persistent rather than isolated incidents. Several failures converged:

  • Automated dispensing cabinet transactions and medication-area removals were not effectively monitored or reconciled, so repeated fentanyl withdrawals went unexplained.
  • Recordkeeping deficiencies made it impossible to reconcile what was dispensed against what was documented as administered or wasted.
  • DEA theft-reporting obligations were not met in a timely manner, delaying regulatory awareness and escalation of a known problem.
  • No surveillance mechanism caught two staff members using diverted fentanyl to the point of fatal overdose — a failure of both analytics and workplace culture.

How It Could Have Been Prevented

  • Establish and enforce a routine review schedule for all controlled substance transactions, with mandatory escalation of discrepancies to the diversion prevention coordinator.
  • Reconcile dispensing records against administration and waste documentation on a closed-loop basis for every shift and unit.
  • Benchmark individual removal and administration rates against anonymous peer comparisons, alerting on outliers before patterns become entrenched.
  • Meet DEA theft-reporting obligations promptly, maintaining a documented chain from discovery to filing to demonstrate timeliness.
  • Conduct periodic unannounced audits of medication areas, including physical counts and access-log review.
  • Foster a visible, non-punitive reporting culture so colleagues can raise concerns about impairment or drug handling before harm occurs.

Related Guidance

Sources